In vitro and in vivo activity of GT-1, a novel siderophore cephalosporin, and GT-055, a broad-spectrum β-lactamase inhibitor, against biothreat and ESKAPE pathogens.
- Resource Type
- Article
- Source
- Journal of Antibiotics; Dec2021, Vol. 74 Issue 12, p884-892, 9p
- Subject
- Language
- ISSN
- 00218820